Khaitan & Co. advised Tata Capital Innovations Fund on its investment in Mitra Biotech Pvt Ltd. It is an Indian based company engaged in the business of research and development and sales of a diagnostic technology platform for personalized cancer treatment and for applications in oncology drug development and other products and applications related thereto. Siddharth Shah was the concerned Partner for the transaction.